Christopher Barker, MD

Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:

  • Employment: Memorial Sloan Kettering Cancer Center:Associate Member:Employee
  • Compensation: Alpha Tau Medical: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 07/01/2024 ;Regeneron: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Honoraria, Travel Expenses-End Date: to present ;EMD Serono: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;Amgen: Research Grants, Research Funding, Research Sa
  • Ownership: none
  • Leadership: Memorial Sloan Kettering Cancer Center:Vice Chair for Clinical Research;National Comprehensive Cancer Network:Panel member

Presentations

Sep 28

2309 - Neoadjuvant Immunotherapy Followed by Response-Adapted Definitive Radiotherapy for Unresectable, Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Dosimetric Analysis of a Phase II Clinical Trial
Hall F
02:30pm - 04:00pm PT
Sep 30

Neoadjuvant Immune Therapy in Cutaneous Malignancies
02:32pm - 02:47pm PT